Free Trial

Parallax Health Sciences (PRLX) Short Interest Ratio & Short Volume

Parallax Health Sciences logo

Parallax Health Sciences Short Interest Data

Parallax Health Sciences (PRLX) has a short interest of 9,000 shares. This marks a ∞ increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 25,010 shares to cover all short positions.

Current Short Interest
9,000 shares
Previous Short Interest
0 shares
Change Vs. Previous Month
+∞
Dollar Volume Sold Short
$414.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
April 15, 2020
Today's Trading Volume
0 shares
Average Trading Volume
25,010 shares
Today's Volume Vs. Average
0%
Short Selling Parallax Health Sciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Parallax Health Sciences and its competitors with MarketBeat's FREE newsletter.

Parallax Health Sciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date

PRLX Short Interest - Frequently Asked Questions

What is Parallax Health Sciences' current short interest?

Short interest is the volume of Parallax Health Sciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 9,000 shares of PRLX short. Learn More on Parallax Health Sciences' current short interest.

Is Parallax Health Sciences' short interest increasing or decreasing?

Parallax Health Sciences saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 9,000 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AbbVie Inc. ($6.93 billion), Charter Communications, Inc. ($4.47 billion), Match Group Inc. ($2.71 billion), The Charles Schwab Corporation ($2.47 billion), Microchip Technology Incorporated ($2.38 billion), The Clorox Company ($2.03 billion), Aurora Cannabis Inc. ($1.85 billion), Wayfair Inc. ($1.84 billion), PDD Holdings Inc. Sponsored ADR ($1.84 billion), and International Flavors & Fragrances Inc. ($1.74 billion). View all of the most shorted stocks.

What does it mean to sell short Parallax Health Sciences stock?

Short selling PRLX is an investing strategy that aims to generate trading profit from Parallax Health Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Parallax Health Sciences?

A short squeeze for Parallax Health Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PRLX, which in turn drives the price of the stock up even further.

How often is Parallax Health Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRLX, twice per month. The most recent reporting period available is April, 15 2020.




This page (OTCMKTS:PRLX) was last updated on 6/29/2025 by MarketBeat.com Staff
From Our Partners